Biomedical, Clinical & Life Sciences

RFA-CA-22-041: 2022 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

UArizona is eligible to submit one application per due date. The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers. 

Internal Deadline
External Deadline
11/18/2022
Solicitation Type

RFA-HD-23-023: 2022 Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

This FOA encourages applications for institutional research career development (K12) programs that support mentored research and career development experiences for scholars pursuing clinical, translational, and/or basic research in pediatric therapeutics. This program constitutes a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution. The primary purpose of this FOA is to ensure that a pipeline of diverse and highly trained workforce is available in pediatric pharmacology-related clinical and biomedical fields that currently have a limited number of researchers. This FOA will support essential research career development opportunities and ensure “protected” time to pursue impactful research experiences for new faculty-level clinical pharmacologists, fostering the transition to productive highly skilled clinical pharmacologist investigators.

This initiative proposes to expand and strengthen the community of clinical pharmacologist investigators engaged in pediatric clinical pharmacology research.

Internal Deadline
External Deadline
12/06/2022

RFA-AI-22-058: 2022 National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID CDSMC, which will support a broad range of critical support services, including data management and processing, safety and pharmacovigilance management and processing, and sample tracking systems for NIAID-funded clinical trials, integrated studies of underlying mechanisms, clinical studies (e.g., longitudinal studies, genetic studies, etc.), and studies to identify and validate surrogates/biomarkers of immune-mediated diseases in the areas of asthma and allergic diseases, autoimmune diseases, and transplantation.

Internal Deadline
External Deadline
11/30/2022

RFA-HD-23-027: 2022 Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2023 (R24 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this funding announcement is to support a coordinating center for the NICHD Population Dynamics Centers Research Infrastructure Programs. The PDRIP is comprised of recipients that have active support from RFA-HD-18-013RFA-HD-19-014RFA-HD-20-015RFA-HD-21-010RFA-HD-22-013, and predecessor and successor announcements.

Internal Deadline
External Deadline
12/02/2022

RFA-DK-22-008: 2022 National Coordinating Center for the George M. OBrien Kidney National Resource Centers (U24 - Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for the George M. O’Brien Kidney Consortium -- National Coordination Center (NCC) to lead a nation-wide effort to advance kidney research. The O’Brien Kidney Consortium will consist of ~8 National Resource Centers (NRCs) tasked with developing and sharing specialized kidney resources tools, technologies, services, and expertise and one NCC to lead, manage, and harmonize all aspects of the Consortium. Specifically, the NCC will: (1) provide administrative support and coordination for the entire Consortium, (2) establish and curate a “one-stop-shop” sharing portal for the entire Consortium, (3) develop and implement a multipronged communication and education plan for researchers and students interested in conducting kidney research to maximize national outreach and impact, (4) ensure that patient viewpoints, priorities, and preferences inform all aspects of the Consortium, and (5) administer and manage a national Opportunity Pool program to address gaps and promote collaboration.

Internal Deadline
External Deadline
12/01/2022

HRSA-23-082: 2022 National Maternal and Child Health Data Resource Center

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of the DRC is to support Title V Maternal and Child Health (MCH) Services Block Grant programs, hereafter referred to as Title V programs, and other MCH partners in accessing and effectively utilizing national and state-level National Survey of Children’s Health (NSCH) data to inform policy and practice. Additionally, the purpose of the DRC is to support broad access to and utilization of the NSCH data through an easy-to-use web platform which provides a user-defined query system for point-and-click access to state and national estimates, curated data files for analyses, maps, and methodological documents designed for a wide audience.

Internal Deadline
External Deadline
11/16/2022

RFA-DK-22-007: 2022 George M. O'Brien Kidney National Resource Centers (U54 - Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for the George M. O’Brien Kidney Consortium --National Resource Centers (NRCs) to lead a nation-wide effort to advance kidney research. By establishing this Consortium, the NIDDK aims to expand the breadth and impact of this program and achieve following outcomes: (1) improved coordination among Centers, (2) enhancement of national outreach and sharing, and (3) promote continuous technological innovations. The Consortium will consist of ~8 National Resource Centers (NRCs) and one National Coordinating Center (NCC). The NRCs will; (1) establish theme-based cores to develop and nationally share unique resources, tools, technologies, services, and expertise that will support and advance kidney research, (2) promote the development of novel resources to stay abreast of emerging trends, (3) Promote inclusion of investigators from diverse scientific disciplines, (4) Promote the inclusion of investigators and fellows from diverse backgrounds, and (5) expand the pool of investigators pursuing kidney research by attracting investigators that are new or from non-renal fields to join the kidney research community.

Internal Deadline
External Deadline
12/1/2022

HRSA-23-029: 2022 FY 2023 National Training and Technical Assistance Partner (NTTAP) Cooperative Agreements

No applicants // Limit: 1 // Tickets Available: 1 

 

NTTAPs develop, deliver, coordinate, and evaluate training and technical assistance (T/TA) to existing and potential Health Center Program award recipients and look-alikes (health centers)1 nationwide, both directly and through collaborations with other Health Resources and Services Administration (HRSA) funded T/TA partners. FY 2023 NTTAP award recipients will receive funding to provide T/TA that support health centers to: Deliver comprehensive care; Address emergent public health issues and health needs; Improve operational effectiveness and quality; and Advance health equity. HRSA will provide funding to NTTAPs to identify health center T/TA needs nationwide and to provide T/TA to support health centers that serve statutorily defined special populations, other health center populations, and through specified development areas.

Internal Deadline
External Deadline
10/14/2022

2022 The Warren Alpert Distinguished Scholar Awards

Ticket #1: COM-P: H-D. Kim

UArizona may submit one nomination per eligible medical school. 

The Warren Alpert Distinguished Scholars program will support individual scientists of exceptional creativity who have an MD or PhD degree (or both) and who have completed a minimum of three years  of a post-doctoral fellowship by July 1, 2023 in the field of  neurosciences and hold a post-doctoral research position at a United States medical school, research institute or academic hospital.

These awards are given as a transitional post-doctoral award for recipients to enable their advance to a full-time faculty member at the Assistant Professor level or higher and/or to assist in the development of a laboratory program that would lead to independent funding. The medical school, research institute or academic hospital appointing the scholar will be awarded $200,000 annually for two years to cover their salary, lab costs, and related expenses.  Under certain circumstances, the awardee may transfer funding to support their faculty position.  Indirect cost of up to 15% of direct costs, may be included in the $200,000.  All applicants are required to provide 75% effort.

Internal Deadline
External Deadline
11/01/2022
Solicitation Type